Description
Discover the revolutionary Aortic Valve Transcatheter Intervention (TAVI), an advanced solution for treating calcific aortic stenosis (AS). Cataloging the latest developments from clinical experts, this brand new handbook delves into the transformation brought by TAVI since its inception by Alain Cribier in 2002. With a focus on the challenges of symptomatic, severe aortic stenosis, this comprehensive guide explores the superiority of TAVI over traditional surgical aortic valve replacement (SAVR) in terms of safety, efficacy, and reduced invasiveness. Suitable for professionals and researchers alike, this book emphasizes optimizing TAVI procedures, enhancing patient outcomes while minimizing complications.
With a calculated annual incidence rate of up to 6% in individuals aged 75 and above, the demand for effective treatments continues to rise. This practical handbook not only discusses various valve design options but also highlights the evolution of TAVI technology, making it a critical read as the strategy advances to younger and lower-risk patients. The integrated evaluation of clinical status, imaging techniques, and laboratory findings ensures readers can implement preventive and therapeutic recommendations effectively. The 288-page publication is meticulously crafted by renowned authors, bringing you essential insights into the dynamic field of transcatheter aortic valve intervention.
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled. Condition: BRAND NEW. ISBN: 9781119720591. Publisher: John Wiley & Sons (UK). Year: 2021.
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled.
Condition: BRAND NEW
ISBN: 9781119720591
Year: 2021
Publisher: John Wiley & Sons (UK)
Pages: 288
Description:
Aortic Valve Transcatheter Intervention
Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.
Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.
This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.
With a calculated annual incidence rate of up to 6% in individuals aged 75 and above, the demand for effective treatments continues to rise. This practical handbook not only discusses various valve design options but also highlights the evolution of TAVI technology, making it a critical read as the strategy advances to younger and lower-risk patients. The integrated evaluation of clinical status, imaging techniques, and laboratory findings ensures readers can implement preventive and therapeutic recommendations effectively. The 288-page publication is meticulously crafted by renowned authors, bringing you essential insights into the dynamic field of transcatheter aortic valve intervention.
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled. Condition: BRAND NEW. ISBN: 9781119720591. Publisher: John Wiley & Sons (UK). Year: 2021.
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled.
Condition: BRAND NEW
ISBN: 9781119720591
Year: 2021
Publisher: John Wiley & Sons (UK)
Pages: 288
Description:
Aortic Valve Transcatheter Intervention
Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.
Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.
This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.